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Abstract
Background
Presenting to primary care with potential cancer symptoms is contingent on one’s ability to
recognize potentially serious symptoms. We investigated differences between smokers and
non-smokers in symptoms experienced, awareness and consulting of potential respiratory,
head and neck cancer symptoms.
Methods
Smokers and non-smokers aged over 50 from Yorkshire general practice lists were sent a
postal questionnaire asking about symptoms, consulting and awareness of cancer symp-
toms. Data were analysed using STATA14.
Results
Response rate after one reminder was 30.5% (1205/3954). Smoking status was associated
with experience of cough (p<0.001), breathlessness (p = 0.002) and tiredness (p = 0.004)
with smokers (25.8% of population) more likely than never-smokers (53.6% of population) to
experience all three symptoms (cough OR = 2.56;95%CI[1.75–3.75], breathlessness OR =
2.39;95%CI[1.43–4.00], tiredness OR = 1.57;95%CI[1.12–2.19]). Smoking status was asso-
ciated with awareness of breathlessness as a potential cancer symptom (p = 0.035) and
consulting for cough (p = 0.011) with smokers less likely to consult than never-smokers
(OR = 0.37;95% CI[0.17–0.80]).
Conclusion
Our findings suggest that current smokers are more likely to experience cough, breathless-
ness and tiredness, but are less likely to consult for cough than never-smokers. To increase
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cancer awareness and promote consulting among smokers, innovative interventions
improving symptom recognition and empowering smokers to seek help are required.
Introduction
Cancer remains one of the UK’s major cause of ill-health, both in terms of morbidity and mor-
tality [1]. There has been increasing interest in how patients and professionals recognise cancer
symptoms [2] particularly since data show that one-year survival figures for many cancers are
poorer in the UK than in comparable European countries [3]. This suggests that people in the
UK are diagnosed at a later point in their cancer history than others in Europe, leading to the
question of why there should be this apparent delay in diagnosis [4].
Recognition of potentially serious symptoms by patients precedes presentation to pri-
mary care and is a key aspect of the pathway to cancer diagnosis [5, 6]. Much of the research
has focused on symptom awareness and indicates that not only is there relatively low aware-
ness of cancer symptoms in UK [7, 8], but also higher perceived barriers to presentation
including normalization of symptoms [9]; interpretation of symptoms based on previous
experiences [10], fear [11], worrying about wasting the doctor’s time [12] and living alone
[13].
In seeking to impact on presentation to primary care with potential cancer symptoms, it is
worthwhile to consider the groups most at risk of developing cancer in order to understand
their awareness of symptoms and how they respond. For example, smoking is associated with
increased risk of several cancers, including head and neck [14, 15] (relative risk [RR] lar-
ynx = 6.14,95%CI [4.55–8.30]; RR oesophageal = 2.14, 95% CI [1.73–2.65]; RR oropharyn-
geal = 2.30, 95%CI [1.94–2.72] and lung cancers (RR lung = 9.28 (95%CI [8.31–10.4]) [16]
which, if diagnosed early, can be treated more successfully with improved outcomes. However,
there is low awareness of potential lung cancer symptoms among smokers [17] although evi-
dence suggests that there is no significant difference in symptom recognition among current
or former smokers [18]. Long–term smokers have been shown to be more likely to present
later to primary care with potential lung cancer symptoms [13, 19]. However, there is currently
limited knowledge of symptom awareness and primary care consultation by smoking status
for head and neck cancers.
Through the identification of those groups at higher risk of cancer, but who are also more
likely to have lower awareness of and less likely to consult with symptoms, we can target cam-
paigns that have been shown to be effective. For example, public health campaigns have been
associated with improving symptom awareness following the first lung cancer campaign in
England. The ‘spontaneous awareness’ (when respondents were asked to name as many symp-
toms of lung cancer as possible) of cough as a lung cancer symptom increased from 54% to
65% post-campaign (p<0.001) [20]. ‘Prompted awareness’ (when respondents were shown a
list of lung cancer symptoms and asked whether they could be a warning sign of lung cancer)
rose to 33% post-campaign from 18% pre-campaign (p<0.001) [20]. An increased number of
lung cancer diagnoses were also observed, alongside a shift in stage distribution and surgical
resections [21].
We therefore sought to investigate the symptom experience, awareness of, and primary care
consultation for symptoms associated with lung and head and neck cancer among people aged
over fifty years in Hull and Leeds according to smoking status.
Symptom experience, cancer awareness, consulting and smoking status
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Materials and methods
Setting and governance
We conducted a cross-sectional questionnaire study between October 2013 and March 2014 in
Hull and Leeds in the Yorkshire and the Humber region (YH). Hull had the highest smoking
prevalence (26.4%) in YH (YH prevalence = 20.1%) in 2014, which was also much higher than
the national prevalence (18.0%) according to the Integrated Household Survey (IHS) [22]. The
prevalence in Leeds was also higher than national prevalence and the fourth highest in YH
(23.1%). Ethical approval was received from the NHS YH-Leeds East Research Ethics Commit-
tee (Reference: 12/YH/0341).
Participants
Sample size estimation. We selected cough as our primary symptom as this was likely to
be the commonest symptom that could potentially be associated with the cancers of interest
[23]. A community survey conducted in Leeds and Bradford estimated the chronic cough
prevalence in smokers and non-smokers as 18% and 11% respectively [24]. In order to detect a
difference of this magnitude, with 90% power, a sample size of 558 smokers and 558 never-
smokers was required. We estimated a response rate of 35% (a conservative estimate of overall
response) [25].
Data collection
The questionnaire development was informed by the: Model of Pathways to Treatment [26],
Cancer Awareness Measure (CAM) [27] and Symptoms Appraisal questionnaire [25]. The
questionnaire comprised sections on the experience of symptoms of lung and head and neck
cancers, pre-existing illnesses/conditions, response to symptoms, triggers to consultation,
understanding/awareness of potential cancer symptoms, symptoms interpretation, health ser-
vices utilization and socio-demographic data (S1 Questionnaire). ‘Cancer’ was not mentioned
in the participant information sheet (PIS) or questionnaire. It was only mentioned in the sec-
tion that explored the respondents’ understanding of potential cancer symptoms, which
included cancer as one of the four illnesses (others were ‘flu’, heart disease and asthma). After
piloting, patients over fifty years (smokers and practice-matched non-smokers) from GP lists
in Hull and Leeds were sent a postal questionnaire (with one reminder). We regarded receiv-
ing a completed questionnaire from a respondent as consent to participate in the study.
Piloting. We recruited 34 volunteers over 50 years old to pilot the questionnaire, 11 were
University of Hull staff members, 4 were members of the public in Hull and 20 members of the
public in Nottingham. Most volunteers were White British (88.2%) and female (67.6%). The
volunteers completed the questionnaire in the presence of the researcher (JuW). On comple-
tion, the respondent was asked to comment on the readability, structure and feasibility of the
questionnaire. A number of issues were raised; for example, a number of respondents asked
what the term ‘persistent’ meant in the ‘Experience of symptoms’ section (pages 6–9, S1 Ques-
tionnaire). This was changed to ‘does/did not go away’ by the researchers (S1 Questionnaire)
Recruitment. Eight practices identified by the National Institute for Health Research
Clinical Research Network (NIHR CRN) were recruited. Each practice was asked to recruit
500 eligible participants, stratified by smoking status and gender. The eligible individuals were
identified using a database search. A GP then screened the list for any patients: who were
unable to give informed consent, with a lung or head and neck cancer diagnosis or unsuitable
for home visits. The practices identified 3954 eligible patients who were sent packs (comprising
the questionnaire, GP letter to patient, a complimentary slip, PIS, and a reply-paid envelope)
Symptom experience, cancer awareness, consulting and smoking status
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via post. A secure, confidential electronic file linking a questionnaire unique identifier with
each patient was created and stored by each practice. About three months later, reminders
were sent once to non-respondents. The practices also provided anonymized, general demo-
graphic information (age and gender) for 2707 (68.5%) non-respondents. We checked for the
study population representativeness using age and gender.
Measurements
Explanatory variables. Smoking status: Consistent with definitions used within NHS
England [28], respondents were asked whether they had ever smoked and those who had not
were regarded as never-smokers. Ex-smokers were those reporting that they had previously
but did not currently smoke. Smokers were those who reported that they were current
smokers.
Respondents were asked to report on their smoking habits; this included the type (ciga-
rettes, including hand-rolled, cigars and pipes) and amount smoked. We used the Centers for
Disease Control and Prevention (CDC) conversion to convert the tobacco and cigars to the
cigarette equivalent [29]: 0.0325 ounces (oz) = 0.9g = 1 cigarette; we modified this to 1 oz = 31
cigarettes; 1 cigar = 20 cigarettes. We graded the number of cigarettes smoked per day accord-
ing to the Office for National Statistics (ONS) [30], that is, light smokers = 0–9 cigarettes/day;
moderate smokers = 10–19 cigarettes/day and heavy smokers = 20+ cigarettes/day. The very
low rate smokers (those who smoke less than one cigarette per day) were also included in the
light smokers’ category [31].
Outcome variables. Symptoms experience (reported symptoms): Respondents were
asked whether they had experienced any of seventeen symptoms (yes/no) in three months
prior completing the questionnaire. The symptoms were persistent cough, persistent shoulder
pain, unexplained breathlessness, tiredness, unexplained weight loss, persistent chest infection,
persistent chest pain, coughing up blood, painful cough, loss of appetite, difficulty swallowing,
change in existing cough, persistent mouth ulcer, numbness of lip/tongue, persistent cold
sore/cut on lip, hoarse voice for more than 3 weeks and neck lump.
Self-reported consulting for at least one potential cancer symptom (consulting): Respon-
dents were asked to indicate whether or not they had seen the doctor for the experienced
symptom listed above (yes/no).
Awareness of at least one potential cancer symptom (awareness): The respondents’ under-
standing of illnesses was sought by asking them to match fifteen symptoms to four illnesses
(including cancer). The fifteen symptoms were persistent cough, persistent shoulder pain,
unexplained breathlessness, tiredness, unexplained weight loss, persistent chest pain, coughing
up blood, difficulty swallowing, persistent mouth ulcer, persistent cold sore/cut on lip, hoarse
voice for more than 3 weeks, neck lump, unexplained pain, sore throat and ‘feeling your heart
pound or race’. We excluded ‘feeling your heart pound or race’ in the ‘Awareness’ section
from our analysis because it is not a potential lung or head and neck cancer symptom and is
associated more with heart disease. If the respondent identified a symptom as a potential can-
cer symptom, they were considered to be aware of that symptom (yes/no). Please note that
some of the symptoms in the ‘Symptoms experienced’ section were not in the ‘Awareness’ sec-
tion and vice versa.
Analysis
Baseline characteristics were produced for broad demographic indicators, smoking status,
‘having cancer experience’ and ‘having a previous cardiorespiratory diagnosis’. We examined
differences in the socio-demographic characteristics by smoking status. The proportions of
Symptom experience, cancer awareness, consulting and smoking status
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symptoms experienced, self-reported consulting and awareness of potential cancer symptoms
were also examined. The strength of association between smoking status and: symptoms expe-
rienced; self-reported consulting; and awareness, for cough, breathlessness, tiredness and
shoulder pain was assessed (Chi-squared test). Logistic regression was used to investigate the
relationship between smoking status and awareness of, experience of and self-reported consul-
tation for cough, breathlessness, tiredness and shoulder pain. Adjustment for demographic
characteristics (age, gender, education and accommodation), previous cancer experience and
cardiorespiratory diagnosis was made in the models. Analyses focused on these symptoms as
they were most commonly reported by our study population and in previous research [32].
Cough, breathlessness and tiredness are among the six key symptoms included in the National
Institute for Health and Care Excellence (NICE) guidelines for suspected lung cancer [33].
Additionally, cough and breathlessness are part of the national cancer awareness campaigns in
England [34]. We regarded missing data as missing-completely-at-random (MCAR) [35].
Data were analyzed using STATA 14.
Results
The response rate after one reminder was 30.5% (1205/3954) (Fig 1). Women and older people
(60–69 years compared to 50–59 years) were more likely to respond (S1 Table). Little’s MCAR
test [36] was not significant when considering the respondents’ age suggesting that data were
missing completely at random (χ2 = 0.051; DF = 1; p = 0.821).
Sample characteristics
The study population comprised 1205 respondents; 45.5% men and 53.1% women (Table 1),
mean age 62.8 years (SD = 8.8; range = 50–98), mostly White British (97.2%). Just over half of
the sample had never smoked (53.6%), with 25.8% smokers and 18.3% ex-smokers. The final
sample comprised more ex-smokers than expected. Among ex-smokers, 71% had stopped
smoking over 12 months prior the study, while 28% had stopped smoking within the previous
12 months. The average number of cigarettes smoked per day by 306 respondents was 12.7
(SD = 7.6, range 0–40); 26.4% were classed as heavy smokers, the proportions of moderate and
light smokers were the same (36.8%). There was no evidence of an association between
Fig 1. Study recruitment- Flow chart illustrating the study recruitment.
https://doi.org/10.1371/journal.pone.0183647.g001
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smoking status and age (p = 0.062), gender (p = 0.297) or ‘having a previous cardiorespiratory
diagnosis’ (p = 0.473). However, there was evidence of a relationship between smoking and
education (p = 0.034), accommodation (p<0.001) and cancer experience (p = 0.003).
Cough
Almost a fifth of our respondents (19.2%) reported experiencing cough; of these, less than half
had consulted their doctor (36.0%) (Table 2), but 60.1% of all respondents were aware that
cough is a potential cancer symptom. Experience of cough was associated with smoking status
(p<0.001), with experience being more common amongst smokers than never-smokers
(adjusted OR = 2.56 95% CI[1.75–3.75]). Amongst the smokers (34.2%) who experienced
cough, only about a quarter consulted for this (24.4%)(Table 2). Smoking status was related to
consulting for cough (p = 0.011) with smokers less likely to consult than never-smokers
(adjusted OR = 0.37 95%CI[0.17–0.80]) (Table 3). There was no evidence of an association
between smoking and awareness that cough could be a cancer symptom (p = 0.898).
Table 1. Sample characteristics, frequencies and association with smoking.
Variable Association with smoking status
Never-smokers Ex-smokers Smokers
Frequency, n(%) Frequency, n(%) Frequency, n(%) Frequency, n(%) Total, n Chi2 p value V
Smoking status n = 1196 - - -
Never smokers 641 (53.6)
Ex-smokers 219 (18.3) - - - -
Smokers 308 (25.8)
Missing 28 (2.3)
Gender n = 1189 n = 600 n = 202 n = 269 n = 1071
Men 541 (45.5) 264 (44.0) 101 (50.0) 127 (47.2) 492 (45.9)
Women 631 (53.1) 336 (56.0) 101 (50.0) 142 (52.8) 579 (54.1) 2.43 0.297 0.05
Missing 17 (1.4)
Age n = 1200 n = 578 n = 195 n = 259 n = 1032
50–59 451 (39.7) 239 (41.4) 69 (35.4) 103 (39.8) 411 (39.8)
60–69 452 (39.8) 212 (36.7) 90 (46.2) 114 (44.0) 416 (40.3) 8.95 0.062 0.07
70+ 233 (20.5) 127 (22.0) 36 (18.5) 42 (16.2) 205 (19.9)
Missing 64 (5.3)
Education n = 1189 n = 576 n = 198 n = 258 n = 1032
Degree 292 (24.6) 161 (28.0) 58 (29.3) 52 (20.2) 271 (26.3) 6.76 0.034 0.08
No degree 837 (70.4) 415 (72.1) 140 (70.7) 206 (79.8) 761 (73.7)
Missing 60 (5.1)
Accommodation n = 1193 n = 598 n = 202 n = 271 n = 1071
Own house 983 (82.4) 521 (87.1) 179 (88.6) 200 (73.8) 900 (84.0) 28.6 <0.001 0.16
Renting 194 (16.3) 77 (12.9) 23 (11.4) 71 (26.2) 171 (16.0)
Missing 16 (1.3)
Cancer experience n = 1056 n = 582 n = 191 n = 257 n = 1030 11.3 0.003 0.1
No experience 114 (10.8) 46 (7.9) 21 (11.0) 40 (15.6) 107 (10.4)
Have experience 941 (89.2) 536 (92.1) 170 (89.0) 217 (84.4) 923 (89.6)
Previous cardiorespiratory diagnosis n = 1057 n = 582 n = 191 n = 258 n = 1031 1.5 0.473 0.04
No 587 (55.6) 331 (56.9) 106 (55.5) 135 (52.3) 572 (55.5)
Yes 469 (44.4) 251 (43.1) 85 (44.5) 123 (47.7) 459 (44.5)
Key: The totals are varied because of missing data; bold figures indicate the statistically significant findings (p0.05); n = total number; v = Crame´r V;
Chi2 = Pearson’s correlation chi2; CI = confidence interval
https://doi.org/10.1371/journal.pone.0183647.t001
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Table 2. Frequencies for symptoms experience, self-reported consulting and awareness of cough, breathlessness, tiredness and shoulder pain
and the association with smoking status.
Association with smoking status
Never-smokers Ex-smokers Smokers
Frequency, n(%) Frequency, n(%) Frequency, n(%) Frequency, n(%) Total, n (%) Chi2 p value V
Cough
Symptoms experience n = 1056 n = 563 n = 185 n = 246 n = 994 40.83 <0.001 0.2
No 814 (77.1) 475 (84.4) 158 (85.4) 162 (65.9) 795 (80.0)
Yes 203 (19.2) 88 (15.6) 27 (14.6) 84 (34.2) 199 (20.0)
Missing 39 (3.7) - - - -
Self-reported consulting n = 203 n = 83 n = 25 n = 82 n = 190
Did not consult 119 (58.6) 43 (51.8) 13 (52.0) 62 (75.6) 118 (62.1)
Consulted 73 (36.0) 40 (48.2) 12 (48.0) 20 (24.4) 72 (37.9) 11.18 0.004 0.24
Did not complete section 11 (5.4) - - - -
Awareness n = 1057 n = 583 n = 191 n = 258 n = 1032
Not aware 422 (39.9) 229 (39.3) 74 (38.7) 111 (43.0) 414 (40.1) 1.23 0.541 0.03
Aware 635 (60.1) 354 (60.7) 117 (61.3) 147 (57.0) 618 (59.9)
Breathlessness
Symptom experience n = 1056 n = 557 n = 180 n = 242 n = 979 25.26 <0.001 0.16
No 887 (84.0) 517 (92.8) 154 (85.6) 196 (81.0) 867 (88.6)
Yes 115 (10.9) 40 (7.2) 26 (14.4) 46 (19.0) 112 (11.4)
Missing 54 (5.1) - - - -
Self-reported consulting n = 115 n = 36 n = 24 n = 40 n = 100
Did not consult 63 (54.8) 23 (63.9) 13 (54.2) 27 (67.5) 63 (63.0)
Consulted 38 (33.0) 13 (36.1) 11 (45.8) 13 (32.5) 37 (37.0) 1.16 0.559 0.11
Did not complete section 14 (12.2) - - - -
Awareness n = 1057 n = 583 n = 191 n = 258 n = 1032
Not aware 786 (74.4) 446 (76.5) 128 (67.0) 198 (76.7) 772 (74.8) 7.55 0.023 0.09
Aware 271 (25.6) 137 (23.5) 63 (33.0) 60 (23.3) 260 (25.2)
Tiredness
Symptoms experience n = 1056 n = 565 n = 183 n = 243 n = 991 11.83 0.003 0.11
No 584 (55.3) 352 (62.3) 95 (51.9) 124 (51.0) 571 (57.6)
Yes 432 (40.9) 213 (37.7) 88 (48.1) 119 (49.0) 420 (42.4)
Missing 40 (3.8) - - - -
Self-reported consulting n = 432 n = 188 n = 80 n = 106 n = 374
Did not consult 298 (69.0) 143 (76.1) 63 (78.8) 84 (79.3) 290 (77.5)
Consulted 87 (20.1) 45 (23.9) 17 (21.3) 22 (20.8) 84 (22.5) 0.48 0.787 0.04
Did not complete section 47 (10.9) - - - -
Awareness n = 1057 n = 583 n = 191 n = 258 n = 1032
Not aware 641 (60.6) 344 (59.0) 109 (57.1) 172 (66.7) 625 (60.6) 5.59 0.061 0.07
Aware 416 (39.4) 239 (41.0) 82 (42.9) 86 (33.3) 407 (39.4)
Shoulder pain
Symptom experience n = 1056 n = 560 n = 185 n = 239 n = 984 4.46 0.107 0.07
No 859 (81.3) 491 (87.7) 153 (82.2) 200 (83.7) 843 (85.7)
Yes 147 (13.9) 69 (12.3) 33 (17.8) 39 (16.3) 141 (14.3)
Missing 50 (4.7) - - - -
Self-reported consulting n = 147 n = 63 n = 27 n = 34 n = 124
Did not consult 76 (51.7) 42 (66.7) 16 (59.3) 15 (44.1) 73 (58.9)
Consulted 52 (35.4) 21 (33.3) 11 (40.7) 19 (55.9) 51 (41.1) 4.64 0.098 0.19
(Continued )
Symptom experience, cancer awareness, consulting and smoking status
PLOS ONE | https://doi.org/10.1371/journal.pone.0183647 August 28, 2017 7 / 13
Table 2. (Continued)
Association with smoking status
Never-smokers Ex-smokers Smokers
Frequency, n(%) Frequency, n(%) Frequency, n(%) Frequency, n(%) Total, n (%) Chi2 p value V
Did not complete section 19 (12.9) - - - -
Awareness n = 1057 n = 583 n = 191 n = 258 n = 1032
Not aware 834 (78.9) 454 (77.9) 151 (79.1) 209 (81.0) 814 (78.9) 1.06 0.589 0.03
Aware 223 (21.1) 129 (22.1) 40 (20.9) 49 (19.0) 218 (21.1)
Key: The totals are varied because of missing data; bold figures indicate the statistically significant findings (p0.05); n = total number; % = percentage;
CI = confidence interval; Adj. = adjusted; OR = odds ratio; Obs = observations; Std dev = standard deviation;v = Crame´r
https://doi.org/10.1371/journal.pone.0183647.t002
Table 3. Univariate and multivariate logistic regression findings for the association between smoking status and reporting, consulting and aware-
ness of cough, breathlessness, tiredness and shoulder pain.
Reported symptom Consulting Awareness
Unadjusted OR
(CI: 95%)
Adjusted OR
(CI: 95%)
p value Unadjusted OR
(CI: 95%)
Adjusted OR
(CI: 95%)
p
value
Unadjusted OR
(CI: 95%)
Adjusted OR
(CI: 95%)
p
value
Cough
Smoking
status
n = 949 n = 910 n = 179 n = 172 n = 983 n = 942 0.898
Never-smokers 1 1 <0.001 1 1 0.011 1 1
Ex-smokers 0.90 (0.56–1.46) 0.87 (0.52–
1.43)
1.21 (0.48–3.07) 1.57 (0.52–
4.70)
1.06 (0.76–1.50) 1.09 (0.75–
1.58)
Smokers 2.93 (2.04–4.19) 2.56 (1.75–
3.75)
0.36 (0.18–0.71) 0.37 (0.17–
0.80)
0.92 (0.68–1.26) 1.01 (0.72–
1.41)
Breathlessness
Smoking
status
n = 935 n = 896 n = 92 n = 86 n = 983 n = 942 0.035
Never-smokers 1 1 0.002 1 1 0.304 1 1
Ex-smokers 2.08 (1.21–3.59) 2.01 (1.12–
3.62)
1.62 (0.55–4.78) 2.34 (0.67–
8.14)
1.58 (1.10–2.26) 1.65 (1.12–
2.41)
Smokers 2.94 (1.84–4.71) 2.39 (1.43–
4.00)
0.81 (0.30–2.15) 0.97 (0.32–
2.97)
1.01 (0.71–1.44) 1.08 (0.74–
1.57)
Tiredness
Smoking
status
n = 948 n = 908 n = 359 n = 345 n = 983 n = 942 0.125
Never-smokers 1 1 0.004 1 1 0.818 1 1
Ex-smokers 1.53 (1.09–2.16) 1.66 (1.16–
2.39)
0.90 (0.48–1.71) 0.89 (0.45–
1.77)
1.13 (0.81–1.58) 1.12 (0.78–
1.62)
Smokers 1.61 (1.18–2.20) 1.57 (1.12–
2.19)
0.83 (0.46–1.49) 0.81 (0.42–
1.56)
0.73 (0.53–1.01) 0.76 (0.54–
1.07)
Shoulder pain
Smoking
status
n = 940 n = 902 n = 123 n = 119 n = 983 n = 942
Never-smokers 1 1 0.081 1 1 0.125 1 1 0.933
Ex-smokers 1.53 (0.97–2.41) 1.69 (1.06–
2.70)
1.38 (0.54–3.48) 1.37 (0.50–
3.73)
0.95 (0.63–1.43) 0.97 (0.64–
1.47)
Smokers 1.37 (0.89–2.10) 1.29 (0.82–
2.04)
2.71 (1.14–6.46) 2.68 (1.04–
6.91)
0.89 (0.61–1.29) 0.93 (0.62–
1.38)
Key: bold figures indicate the statistically significant findings (p0.05); n = total number; % = percentage; CI = confidence interval; OR = odds ratio; we
adjusted for age, gender, education, accommodation, cancer experience and ‘having a previous cardiorespiratory diagnosis’.
https://doi.org/10.1371/journal.pone.0183647.t003
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Breathlessness
Just over a tenth of the respondents (10.9%) reported experiencing breathlessness. A third of
those experiencing the symptom consulted (33.0%) but only about a quarter (25.6%) were
aware that breathlessness is a potential cancer symptom (Table 2). Experience of breathlessness
was associated with smoking status (p = 0.002) and was more common amongst smokers than
never-smokers (adjusted OR = 2.39 95% CI[1.43–4.00]). Over a fifth of smokers were aware
that breathlessness is a potential cancer symptom (23.3%). Smoking status was associated with
awareness that breathlessness was a potential cancer symptom (p = 0.035) with ex-smokers
more likely to be aware than never-smokers (adjusted OR = 1.65 95% CI [1.12–2.41])
(Table 3). There was no evidence of an association between smoking and consulting for
breathlessness (p = 0.304).
Tiredness
Less than half of our respondents (40.9%) reported experiencing tiredness; of these, about a fifth
consulted their doctor (20.1%) (Table 2) and 39.4% of all respondents were aware that tiredness is
a potential cancer symptom. Smoking status was associated with experience of tiredness (p =
0.004) with tiredness being more common amongst smokers than never-smokers (OR = 1.57 95%
CI [1.12–2.19]). There was no evidence of an association between smoking and consulting for
tiredness (p = 0.818) or awareness of tiredness as a potential cancer symptom (p = 0.125).
Shoulder pain
Just over a tenth of our respondents (13.9%) reported experiencing shoulder pain. Of these,
less than half had consulted (35.4%) (Table 2), but about a fifth (21.1%) of all respondents were
aware that shoulder pain is a potential cancer symptom. There was no evidence of an associa-
tion between smoking and experiencing shoulder pain (p = 0.081); smoking and consulting
(p = 0.125) or smoking and awareness of shoulder pain as a potential cancer symptom
(p = 0.933) (Table 3).
Discussion
Main findings
Smoking was associated with increased experience of cough, breathlessness and tiredness. Smok-
ers were more likely than never-smokers to experience the three symptoms while ex-smokers
were more likely than never-smokers to experience breathlessness and tiredness. Smoking status
was associated with consulting for cough but not for the other three symptoms. Smokers were less
likely to consult for cough than never-smokers. Smoking status was associated with awareness for
breathlessness as a potential cancer symptom but not with the other three symptoms. Ex-smokers
were more likely than never-smokers to be aware of breathlessness as a potential cancer symptom
while smokers were just as aware of breathlessness as never-smokers.
Comparison with other studies and possible explanations for our findings
Being a current smoker was associated with increased experience of cough, breathlessness and
tiredness, which are among the six key symptoms associated with suspected lung cancer [33].
It was also associated with consulting for cough as confirmed by Friedemann Smith et al [19]
Previous evidence has suggested that generally cough is not recognized as a potential cancer
symptom hence the time taken to present to the doctor with cough is longer [6]. This is espe-
cially the case for smokers, who usually have a ‘smoker’s cough’ and so will normalize cough
[9]. This may lead to consulting their doctor later than average [13]. Other evidence suggested
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that smokers were less likely than never-smokers to use preventive/cancer screening services
[37]. There was no association of smoking status with consulting for the other three symptoms
probably because there is generally low awareness of potential cancer symptoms [8].
Previous research suggested that breathlessness rarely occurred in isolation and that it nor-
mally occurred in combination with other symptoms associated with lung cancer [23]. This
therefore highlights the importance of focusing on the multiple symptoms of lung cancer
[32,33], particularly in public health media campaigns.
Strengths and limitations
This is the first study to focus on experience of-, consulting and awareness of symptoms sug-
gestive of lung and/or head and neck cancer in relation to smoking status. Previous research
has mainly focused on a single area such as prevalence [24], awareness [7,18,21], or consulting
[13,22]. There is limited evidence combining these three areas. Most evidence relating to can-
cer focuses on lung cancer [16,17], with less evidence on head and neck cancers [14,15].
Ours is also the first study to focus on experience of-, consulting and awareness of symp-
toms suggestive of lung and/or head and neck cancers among smokers over 50 years, a group
at high risk of several cancers, and to sample in such a way as to obtain a reasonable return
from smokers. We obtained a similar response rate to similar postal questionnaire studies
[38,39]. We also achieved the proposed sample size probably because our recruitment areas
had higher than average smoking prevalence than the YH and English figures [22]. Our find-
ings for symptoms experienced and consulting were empirical unlike the awareness findings,
which were not empirical findings, but reflected the respondents’ health literacy. We were
therefore able to obtain estimates of symptoms experienced and consulting within our study
population. Cough, breathlessness, tiredness and shoulder pain are common and are among
the key symptoms for suspected lung cancer in the NICE guidelines [33] therefore these find-
ings are clinically relevant. We did not mention ‘cancer’ in the PIS and questionnaire; we
referred to the questionnaire as the ‘Symptoms Awareness Study’ to reduce the risk of biased
responses from our respondents. This was done so as to reduce/prevent the respondents’ over-
reporting that they consulted for a given symptom if the study had been about ‘cancer’. This
way we were more likely to obtain the respondents’ true consulting behaviour.
Smoking status was self-reported, which may be a valid marker for assessing tobacco expo-
sure [40]. However, when considering the self-reported never-smokers caution should be
taken since there might be the possibility of misclassification because of stigma whereby, the
‘never-smoker’ might have lied about their smoking status. To avoid this, biochemical tests,
which are more accurate, are recommended [40]. This was a postal questionnaire which sug-
gests that people with low literacy skills may have been excluded. The study respondents were
mostly White British with very limited ethnic minority involvement suggesting that these find-
ings cannot be generalized to a multicultural community and may instead be relevant to a sim-
ilar population. We do not have information on the number of ethnic minority individuals
who were invited to participate in the study; therefore we do not know whether there was a
non-response bias among the ethnic minority groups. The response rate was low although
within the parameters of questionnaire studies [38,39], thereby suggesting the possibility of
bias in the study sample. Although our criterion for recruitment was ‘no cancer diagnosis’, few
respondents were diagnosed with cancer; to minimize this effect on cancer awareness, we con-
trolled for ‘cancer experience’ in adjusted analyses. Additionally, since these symptoms are
also present in other non-cancer diseases (cardiorespiratory conditions) and could influence
our consulting findings, we controlled for ‘having previous cardiorespiratory diagnosis’.
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Implication
Our findings highlight the importance of targeting not only smokers but ex-smokers as they
also reported experiencing breathlessness and tiredness, some of the key symptoms associated
with lung cancer [33]. Our findings also suggest that cancer awareness interventions should
focus on the key potential cancer symptoms rather than a singular symptom [23,32,33]. Draw-
ing on the consulting findings, innovative interventions targeting smokers, particularly those
with cough symptoms, to improve their consulting behavior should be considered. In order to
understand this population’s low consulting behavior, further work on the attributions of
potential cancer symptoms in older people should be considered.
Conclusion
Our findings highlight the need to increase cancer awareness and promote consulting among
smokers therefore innovative interventions improving symptom recognition and empowering
smokers to seek help are required.
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